ArticleMolecular and cellular biology2004
Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 45 citations in OpenAlex.
- Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.Breast cancer research : BCR · 2018Article
- MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells.Autophagy · 2018Article
- Review
- Role of MTA1 in cancer progression and metastasis.Cancer metastasis reviews · 2014Review
- The NuRD architecture.Cellular and molecular life sciences : CMLS · 2013Review
- A network module-based method for identifying cancer prognostic signatures.Genome biology · 2012Article
- E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.Proceedings of the National Academy of Sciences of the United States of America · 2009Article
- The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.Clinical & experimental metastasis · 2009Review
- Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.Oncogene · 2008Article
- MTA family of coregulators in nuclear receptor biology and pathology.Nuclear receptor signaling · 2007Review
- Corepressors of agonist-bound nuclear receptors.Toxicology and applied pharmacology · 2007Review
- MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.Journal of mammary gland biology and neoplasia · 2007Review
- MTA1, a transcriptional activator of breast cancer amplified sequence 3.Proceedings of the National Academy of Sciences of the United States of America · 2006Article
- Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.The EMBO journal · 2006Article
- CRIPak, a novel endogenous Pak1 inhibitor.Oncogene · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
The transcriptional activity of estrogen receptor alpha (ER-alpha) is modified by regulatory action and interactions of coactivators and corepressors. Recent studies have shown that the metastasis-associated protein 1 (MTA1) represses estrogen receptor element (ERE)-driven transcription in breast cancer cells. With a yeast two-hybrid screen to clone MTA1-interacting proteins, we identified a known nuclear receptor coregulator (NRIF3) as an MTA1-binding protein. NRIF3 interacted with MTA1 both in vitro and in vivo. NRIF3 bound to the C-terminal region of MTA1, while MTA1 bound to the N-terminal region of NRIF3, containing one nuclear receptor interaction LXXLL motif. We showed that NRIF3 is an ER coactivator, hyperstimulated ER transactivation functions, and associated with the endogenous ER and its target gene promoter. MTA1 repressed NRIF3-mediated stimulation of ERE-driven transcription and interfered with NRIF3's association with the ER target gene chromatin. In addition, NRIF3 deregulation enhanced the responsiveness of breast cancer cells to estrogen-induced stimulation of growth and anchorage independence. Furthermore, we found that NRIF3 is an estrogen-inducible gene and activated ER associated with the ER response element in the NRIF3 gene promoter. These findings suggest that NRIF3, an MTA1-interacting protein, is an estrogen-inducible gene and that regulatory interactions between MTA1 and NRIF3 might be important in modulating the sensitivity of breast cancer cells to estrogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.